Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

Clinical trial NCT02485041 · COMPLETED

Trial details

NCT number: NCT02485041
Sponsor: SK Chemicals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction Potentiation

Start date: 2014-11-01
Primary completion: 2014-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.